Addus HomeCare announced a $162 million stock offering Thursday that will help fund its planned purchase of Gentiva’s home care business.
The Frisco, Texas-based company is offering 1.5 million shares of common stock priced at $108 per share, according to a news release. Addus said it intends to use roughly half of the money raised to repay outstanding debt from its credit facility and the rest to fund the proposed $305 million Gentiva deal and any other future acquisitions. Addus offers home care, home health and hospice services in more than 200 locations across 23 states.
Related: CMS proposes 1.7% Medicare cut for home health providers
Bank of America Securities and Jefferies are the main underwriters of the stock offering. Oppenheimer and Company, Raymond James, RBC Capital Markets and Stephens are co-underwriters. The company said it expects the offering to close Friday, subject to customary closing conditions.